Lupus. Multiple Sclerosis (MS). Crohn’s disease. Diabetes. Infection-associated chronic illnesses (IACCIs). Long COVID.... Read More
Many cutting-edge medicines come with sky-high price tags, leaving patients struggling to afford them. Biosimilars were introduced to help... Read More
Americans remain deeply concerned by the ongoing inflation pressures on their pocketbooks, including medical costs—which now beats out... Read More
Public goods create a peculiar dilemma: everyone likes the benefits, but paying for them is another matter. Economists call this the... Read More
For nearly three years, the pharmaceutical industry has unsuccessfully waged a litigation campaign against the Medicare drug price... Read More
Controlling the spread of many infections, including measles, depends on trust in public health, which is eroding. Read More
When congressional Republicans blocked the extension of the enhanced subsidies under the Affordable Care Act, it was estimated that many... Read More
But one healthy reform does not mean medical education has cured its deeper ailments. Read More
Over the past 18 months there has been a renewed interest in weeding out government waste, fraud and improper payments. Read More
With the right steps, it’s possible to put type 2 diabetes into remission and restore healthy blood glucose levels. But how do you get... Read More
A groundbreaking study released by Unleash Prosperity Now finds the U.S. economy would gain by $180 trillion over the next decade were we... Read More
In 1974, Congress, in its infamous stupidity, required states to adopt “certificate of need” laws as a condition of receiving... Read More
The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More
Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More
I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More
If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More
The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More
On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More
This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More
Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More
This is a difficult moment for Roe v. Wade to have fallen.... Read More
If Congress and the administration do not plan and work together, the end of the old emergency will only mark the beginning of a new emergency.... Read More
The Affordable Care Act has faded into the political background since Republicans failed to repeal the entitlement in 2017, but ObamaCare still doesn't work as promised. The Biden Administration said this week that it will throw more money at one problem, and the result will be to hook more Americans on government subsidies. ... Read More
